Sinopharm Group Co (FRA:X2S) Dividend Payout Ratio : 0.73 (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sinopharm Group Co's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.73.

The historical rank and industry rank for Sinopharm Group Co's Dividend Payout Ratio or its related term are showing as below:

FRA:X2S' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.21 Med: 0.24 Max: 0.29
Current: 0.29

During the past 13 years, the highest Dividend Payout Ratio of Sinopharm Group Co was 0.29. The lowest was 0.21. And the median was 0.24.

FRA:X2S's Dividend Payout Ratio is ranked better than
65.52% of 58 companies
in the Medical Distribution industry
Industry Median: 0.4 vs FRA:X2S: 0.29

As of today (2025-03-02), the Dividend Yield % of Sinopharm Group Co is 4.67%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Sinopharm Group Co was 5.85%. The lowest was 0.86%. And the median was 2.70%.

Sinopharm Group Co's Dividends per Share for the months ended in Jun. 2024 was €0.11.

During the past 12 months, Sinopharm Group Co's average Dividends Per Share Growth Rate was 5.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 8.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 7.50% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 11.90% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sinopharm Group Co was 198.40% per year. The lowest was 6.10% per year. And the median was 13.20% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Sinopharm Group Co Dividend Payout Ratio Historical Data

The historical data trend for Sinopharm Group Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Dividend Payout Ratio Chart

Sinopharm Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.22

0.21

0.23

0.25

Sinopharm Group Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Dividend Payout Ratio	Get a 7-Day Free Trial															0.58	-	0.60	-	0.73

Competitive Comparison of Sinopharm Group Co's Dividend Payout Ratio

For the Medical Distribution subindustry, Sinopharm Group Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinopharm Group Co's Dividend Payout Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sinopharm Group Co's Dividend Payout Ratio falls into.

Sinopharm Group Co Dividend Payout Ratio Calculation

Sinopharm Group Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0.107	/	0.421
	=	0.25

Sinopharm Group Co's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2024 )	/	EPS without NRI (Q: Jun. 2024 )
	=	0.114	/	0.157
	=	0.73

Sinopharm Group Co (FRA:X2S) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Sinopharm Group Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (FRA:X2S) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

SHTDY:USA SHTDF:USA 01099:Hong Kong

Address

No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023

Website

http://www.sinopharmgroup.com.cn

Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.

Sinopharm Group Co Headlines

No Headlines